1. Inhibitory Activity of 4-Benzylidene Oxazolones Derivatives of Cinnamic Acid on Human Acetylcholinesterase and Cognitive Improvements in a Mouse Model.
- Author
-
Ramírez-Ruiz AM, Ávila-Cossío ME, Estolano-Cobián A, Cornejo-Bravo JM, Martinez AL, Córdova-Guerrero I, Cota-Ramírez BR, Carranza-Ambriz KP, Rivero IA, and Serrano-Medina A
- Subjects
- Animals, Mice, Humans, Molecular Docking Simulation, Oxazolone, Cholinesterase Inhibitors chemistry, Disease Models, Animal, Cognition, Structure-Activity Relationship, Acetylcholinesterase metabolism, Alzheimer Disease
- Abstract
We synthesized seven ( Z )-benzylidene-2-( E )-styryloxazol-5(4 H )-ones derivatives of cinnamic acid and evaluated the ability of these compounds to inhibit human acetylcholinesterase (hAChE). The most potent compound was evaluated for cognitive improvement in short-term memory. The seven compounds reversibly inhibited the hAChE between 51 and 75% at 300 μM, showed an affinity ( K
i ) from 2 to 198 μM, and an IC50 from 9 to 246 μM. Molecular docking studies revealed that all binding moieties are involved in the non-covalent interactions with hAChE for all compounds. In addition, in silico pharmacokinetic analysis was carried out to predict the compounds' blood-brain barrier (BBB) permeability. The most potent inhibitor of hAChE significantly improved cognitive impairment in a modified Y-maze test (5 μmol/kg) and an Object Recognition Test (10 μmol/kg). Our results can help the rational design of hAChE inhibitors to work as potential candidates for treating cognitive disorders.- Published
- 2023
- Full Text
- View/download PDF